Total Return Level Chart

View Total Return Level for SXTP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Return Level Chart
Start Trial

Historical Total Return Level Data

View and export this data back to 2023. Start Trial.
Date Value
September 16, 2026 0.924
September 15, 2026 0.8464
September 14, 2026 0.8985
September 11, 2026 0.90
September 10, 2026 0.93
September 09, 2026 0.9402
September 08, 2026 0.9768
September 04, 2026 0.9193
September 03, 2026 0.9301
September 02, 2026 0.9495
September 01, 2026 1.02
August 31, 2026 1.08
August 28, 2026 1.03
August 27, 2026 1.06
August 26, 2026 1.08
August 25, 2026 1.13
August 24, 2026 1.08
August 21, 2026 1.13
August 20, 2026 1.13
August 19, 2026 1.13
August 18, 2026 1.12
August 17, 2026 1.08
August 14, 2026 1.195
August 13, 2026 1.18
August 12, 2026 1.13
Date Value
August 11, 2026 1.13
August 10, 2026 1.13
August 07, 2026 1.12
August 06, 2026 1.15
August 05, 2026 1.22
August 04, 2026 1.23
August 03, 2026 1.16
July 31, 2026 1.17
July 30, 2026 1.25
July 29, 2026 1.49
July 28, 2026 1.50
July 27, 2026 1.57
July 24, 2026 1.48
July 23, 2026 1.49
July 22, 2026 1.55
July 21, 2026 1.57
July 20, 2026 1.51
July 17, 2026 1.51
July 16, 2026 1.52
July 15, 2026 1.55
July 14, 2026 1.46
July 13, 2026 1.45
July 10, 2026 1.56
July 09, 2026 1.56
July 08, 2026 1.55

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
Harrow, Inc. 34.21
ANI Pharmaceuticals, Inc. 73.59
Corcept Therapeutics, Inc. 111.81
Veru, Inc. 2.712
Johnson & Johnson 637.79